Miranda D. Grounds

35 Stirling Highway
Perth, WA 6009, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 82 publications

Insights into the heterogeneous muscle lipidome of dysferlin-deficient mice: effects of age, muscle type, and sex.

Insights into the heterogeneous muscle lipidome of dysferlin-deficient mice: effects of age, muscle type, and sex.

Journal: Skeletal muscle

Published: December 15, 2025

Age-related changes and lack of effect of midlife resistance wheel exercise on afferent connectivity of lumbar alpha motor neurons in ageing mouse spinal cord.

Age-related changes and lack of effect of midlife resistance wheel exercise on afferent connectivity of lumbar alpha motor neurons in ageing mouse spinal cord.

Journal: Biogerontology

Published: August 13, 2025

Pharmacology and macrophage modulation of HPGDS inhibitor PK007 demonstrate reduced disease severity in DMD-affected muscles of the mdx mouse model.

Pharmacology and macrophage modulation of HPGDS inhibitor PK007 demonstrate reduced disease severity in DMD-affected muscles of the mdx mouse model.

Journal: Skeletal muscle

Published: November 29, 2024

Sarcopenia.

Sarcopenia.

Journal: Nature reviews. Disease primers

Published: August 12, 2024

Multimodal three-dimensional characterization of murine skeletal muscle micro-scale elasticity, structure, and composition: Impact of dysferlinopathy, Duchenne muscular dystrophy, and age on three hind-limb muscles.

Multimodal three-dimensional characterization of murine skeletal muscle micro-scale elasticity, structure, and composition: Impact of dysferlinopathy, Duchenne muscular dystrophy, and age on three hind-limb muscles.

Journal: Journal of the mechanical behavior of biomedical materials

Published: May 27, 2024

Pilot investigations into the mechanistic basis for adverse effects of glucocorticoids in dysferlinopathy.

Pilot investigations into the mechanistic basis for adverse effects of glucocorticoids in dysferlinopathy.

Journal: Skeletal muscle

Published: April 21, 2024

Oxidised Albumin Levels in Plasma and Skeletal Muscle as Biomarkers of Disease Progression and Treatment Efficacy in Dystrophic mdx Mice.

Oxidised Albumin Levels in Plasma and Skeletal Muscle as Biomarkers of Disease Progression and Treatment Efficacy in Dystrophic mdx Mice.

Journal: Antioxidants (Basel, Switzerland)

Published: April 21, 2024

Considering the Promise of Vamorolone for Treating Duchenne Muscular Dystrophy.

Considering the Promise of Vamorolone for Treating Duchenne Muscular Dystrophy.

Journal: Journal of neuromuscular diseases

Published: November 06, 2023

Hallmarks of ageing in human skeletal muscle and implications for understanding the pathophysiology of sarcopenia in women and men.

Hallmarks of ageing in human skeletal muscle and implications for understanding the pathophysiology of sarcopenia in women and men.

Journal: Clinical science (London, England : 1979)

Published: July 31, 2023

Correction: Dysferlin-deficiency has greater impact on function of slow muscles, compared with fast, in aged BLAJ mice.

Correction: Dysferlin-deficiency has greater impact on function of slow muscles, compared with fast, in aged BLAJ mice.

Journal: PloS one

Published: May 22, 2023

Slow or fast: Implications of myofibre type and associated differences for manifestation of neuromuscular disorders.

Slow or fast: Implications of myofibre type and associated differences for manifestation of neuromuscular disorders.

Journal: Acta physiologica (Oxford, England)

Published: December 22, 2022

Muscle Pathology in Dystrophic Rats and Zebrafish Is Unresponsive to Taurine Treatment, Compared to the mdx Mouse Model for Duchenne Muscular Dystrophy.

Muscle Pathology in Dystrophic Rats and Zebrafish Is Unresponsive to Taurine Treatment, Compared to the mdx Mouse Model for Duchenne Muscular Dystrophy.

Journal: Metabolites

Published: November 30, 2022

Showing 1-12 of 82

Last Updated: 09/26/2026